Literature DB >> 16199897

Expression of hypoxia-inducible factor 1alpha and cathepsin D in pituitary adenomas.

Daizo Yoshida1, Kyongsong Kim, Michio Yamazaki, Akira Teramoto.   

Abstract

Hypoxia-inducible factor (HIF)-1alpha is a crucial transcription factor involved in the adaptive response to hypoxia, whereas cathepsin D, which regulates angiostatin in several cancer cell lines, has been reported to be upregulated by HIF-1alpha. In order to determine the involvement of angiogenesis in pituitary adenomas, we studied the expression of both HIF-1alpha and cathepsin D in tissues from 58 patients (39 women, 19 men, ranging in age from 20 to 78 yr), sorted by histological group, and assayed by double immunohistochemistry. HIF-1alpha immunoreactivity, confined to the nucleoplasm, was present in both tumor and vascular endothelial cells. There was no difference in microvascular density (p = 0.7761) by histotype. ACTH-producing adenomas showed the lowest level of HIF-1alpha, whereas prolactin (PRL)-producing adenomas and HIF-1alpha-positive microvessels showed the highest (p < 0.001). In contrast, the lowest expression of cathepsin D was observed in PRL-producing adenomas, whereas the highest expression was detected in ACTH-producing adenomas (p < 0.0001). Imaging analysis with fluorescence double immunohistochemistry showed that HIF-1alpha-negative tumor cells did not express significantly higher levels of cathepsin D. In these poorly vascularized tumors, the hypoxic marker HIF-1alpha may not downregulate cathepsin D. The mechanisms of tumor angiogenesis and cell invasion in pituitary adenomas may differ from those in other tumor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199897     DOI: 10.1385/ep:16:2:123

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  33 in total

1.  An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells.

Authors:  A Jang; R P Hill
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

2.  Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma.

Authors:  M C González-Vela; M F Garijo; F Fernández; L Buelta; J F Val-Bernal
Journal:  Histopathology       Date:  1999-01       Impact factor: 5.087

3.  Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive?

Authors:  S Yokoyama; H Hirano; K Moroki; M Goto; S Imamura; J I Kuratsu
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

4.  Angiogenesis in pituitary adenomas and the normal pituitary gland.

Authors:  H E Turner; Z Nagy; K C Gatter; M M Esiri; A L Harris; J A Wass
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

Review 5.  Angiogenesis in pituitary adenomas.

Authors:  Shozo Yamada; Kouji Takada
Journal:  Microsc Res Tech       Date:  2003-02-01       Impact factor: 2.769

6.  Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.

Authors:  A Lösch; M Schindl; P Kohlberger; J Lahodny; G Breitenecker; R Horvat; P Birner
Journal:  Gynecol Oncol       Date:  2004-02       Impact factor: 5.482

7.  The association of the expression of vascular endothelial growth factor with the cystic component and haemorrhage in pituitary adenoma.

Authors:  Shinji Fukui; Naoki Otani; Hiroshi Nawashiro; Akiko Yano; Namiko Nomura; Aya M Tokumaru; Takahito Miyazawa; Akira Ohnuki; Nobusuke Tsuzuki; Hiroshi Katoh; Shoichiro Ishihara; Katsuji Shima; Hidetoshi Ooigawa
Journal:  J Clin Neurosci       Date:  2003-05       Impact factor: 1.961

8.  Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression.

Authors:  Tsunenori Kodama; Noriaki Shimizu; Noritada Yoshikawa; Yuichi Makino; Rika Ouchida; Kensaku Okamoto; Tetsuya Hisada; Hiroshi Nakamura; Chikao Morimoto; Hirotoshi Tanaka
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

9.  Immunocytochemical Investigations on the Vascularization of Pituitary Adenomas.

Authors:  Marek Pawlikowski; Hanna Pisarek; Maria Jaranowska
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

10.  Hypoxia inhibits expression of prolactin and secretion of cathepsin-D by the GH4C1 pituitary adenoma cell line.

Authors:  Gabriela Cosío; Michael C Jeziorski; Fernando López-Barrera; Gonzalo Martínez De La Escalera; Carmen Clapp
Journal:  Lab Invest       Date:  2003-11       Impact factor: 5.662

View more
  9 in total

1.  Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression.

Authors:  Anniina Raitila; Heli J Lehtonen; Johanna Arola; Elina Heliövaara; Manuel Ahlsten; Marianthi Georgitsi; Anu Jalanko; Anders Paetau; Lauri A Aaltonen; Auli Karhu
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

2.  Phosphorylation of cAMP response element binding protein (CREB) as a marker of hypoxia in pituitary adenoma.

Authors:  Daijiro Morimoto; Daizo Yoshida; Masahiro Noha; Masanori Suzuki; R Yoshiyuki Osamura; Akira Teramoto
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

3.  Expression of laminin beta2: a novel marker of hypoxia in pituitary adenomas.

Authors:  Yijun Bao; Daizo Yoshida; Daijiro Morimoto; Akira Teramoto
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

4.  Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia.

Authors:  Ryutaro Nomura; Daizo Yoshida; Akira Teramoto
Journal:  J Neurooncol       Date:  2009-03-12       Impact factor: 4.130

5.  Identification of differentially coexpressed genes in gonadotrope tumors and normal pituitary using bioinformatics methods.

Authors:  Tao Cai; Jie Xiao; Zhi-Fei Wang; Qiang Liu; Hao Wu; Yuan-Zheng Qiu
Journal:  Pathol Oncol Res       Date:  2013-11-07       Impact factor: 3.201

Review 6.  Autophagy in normal pituitary and pituitary tumor cells and its potential role in the actions of somatostatin receptor ligands in acromegaly.

Authors:  Giovanni Tulipano; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2021-04-05       Impact factor: 6.514

Review 7.  Genetically engineered mouse models of pituitary tumors.

Authors:  David A Cano; Alfonso Soto-Moreno; Alfonso Leal-Cerro
Journal:  Front Oncol       Date:  2014-08-01       Impact factor: 6.244

8.  GLUT3 expression in cystic change induced by hypoxia in pituitary adenomas.

Authors:  Tao Mei; Jianhe Zhang; Liangfeng Wei; Xingfeng Qi; Yiming Ma; Xianhua Liu; Shaohua Chen; Songyuan Li; Jianwu Wu; Shousen Wang
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

9.  Evidence for the Capability of Roxadustat (FG-4592), an Oral HIF Prolyl-Hydroxylase Inhibitor, to Perturb Membrane Ionic Currents: An Unidentified yet Important Action.

Authors:  Wei-Ting Chang; Yi-Ching Lo; Zi-Han Gao; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.